Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J, Deloitte launch Illustrate Change, a library of diverse medical images
Medical Marketing and Media
Tue, 06/20/23 - 09:52 pm
Tags:
JNJ, Deloitte, medical images
Abbott’s $1.9B electrophysiology unit threatened by pulsed field ablation: analysts
Medtech Dive
Tue, 06/13/23 - 10:54 pm
Tags:
Medtech, Abbott Labs, pulsed field ablation, JNJ, Medtronic, Boston Scientific
EHA 2023: Janssen’s talquetamab shows promise in multiple myeloma
Clinical Trials Arena
Tue, 06/13/23 - 10:39 am
Tags:
talquetamab, JNJ, Multiple Myeloma
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
Tags:
JNJ, Stelara, biosimilars, legal, patents, Teva Pharmaceutical, Alvotech
Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement
BioSpace
Mon, 06/12/23 - 10:15 am
Tags:
opioids, opioid crisis, legal, pharmacies, McKesson, AmerisourceBergen, Cardinal Health, Teva Pharmaceutical, AbbVie, JNJ
Alkermes, after arbitration win over J&J, jacks up revenue forecast by $425M
Fierce Pharma
Wed, 06/7/23 - 10:18 am
Tags:
Alkermes, JNJ, nanocrystals
Abiomed heart pump recall labeled Class I by FDA, no deaths reported
Medtech Dive
Tue, 06/6/23 - 09:55 am
Tags:
JNJ, Abiomed, devices, Medtech, Impella 5.5, product recalls, device recalls
ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial
Fierce Pharma
Mon, 06/5/23 - 10:02 pm
Tags:
ASCO 2023, JNJ, Balversa, bladder cancer
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
Tags:
ASCO 2023, JNJ, Legend Biotech, Carvykti, CAR-T, Multiple Myeloma
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
Tags:
AstraZeneca, IBD, AbbVie, JNJ, brazikumab, Skyrizi, Stelara
Johnson & Johnson cites rebates and discounts for drug price increases
Fierce Pharma
Mon, 05/29/23 - 12:09 pm
Tags:
JNJ, drug pricing, drug rebates, drug discounts
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
Thu, 05/25/23 - 12:48 pm
Tags:
JNJ, Janssen, Tremfya, psoriasis, real world data
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
Tags:
JNJ, Amgen, patents, Stelara, biosimilars, legal
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
Thu, 05/18/23 - 11:16 am
Tags:
JNJ, schizophrenia, generics, Trinza, Viatris
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA, drug approvals, accelerated approvals, AbbVie, AstraZeneca, Bayer, Bristol Myers Squibb, JNJ, Merck, Merck KGaA, Novartis, Pfizer
Janssen’s Tremyfa scores success in Phase III ulcerative colitis trial
Clinical Trials Arena
Wed, 05/10/23 - 10:02 am
Tags:
JNJ, Janssen, clinical trials, Tremyfa, ulcerative colitis
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Motley Fool
Mon, 05/8/23 - 11:46 pm
Tags:
JNJ, consumer health, spinoffs, Kenvue
Judge orders J&J, talc opponents to engage in settlement talks
Fierce Pharma
Fri, 05/5/23 - 10:15 am
Tags:
JNJ, legal, bankruptcy
J&J sets top price for consumer health unit Kenvue’s IPO
Pharmaphorum
Thu, 05/4/23 - 09:57 am
Tags:
JNJ, spinoff, Kenvue, IPOs, consumer health
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
BioSpace
Tue, 05/2/23 - 11:46 am
Tags:
JNJ, Janssen, Cellular Biomedicine, CAR-T, diffuse large B-cell lymphoma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.